Inactive Instrument

Analyst Reco. Novo Nordisk A/S Xetra

Equities

End-of-day quote Xetra Other stock markets
- ^EUR	-

17/05	Roche: share price stands out, Deutsche Bank in support	CF
16/05	Health Care Flat as Momentum Wanes -- Health Care Roundup	DJ

NOVO NORDISK : UBS sticks Neutral	15/05	ZD
NOVO NORDISK : JP Morgan reaffirms its Buy rating	14/05	ZD
NOVO NORDISK : UBS reaffirms its Neutral rating	14/05	ZD
Stifel Lifts Novo Nordisk PT, Keeps Buy Recommendation	14/05	MT
NOVO NORDISK : Stifel raises its target price	14/05	CF
Novo Nordisk Reportedly Asked by US Senator to Reduce Prices of Ozempic, Wegovy Drugs in US	13/05	MT
Novo Nordisk Plans First Bond Sale in 2 Years	13/05	MT
NOVO NORDISK : Berenberg reiterates its Neutral rating	08/05	ZD
Novo Nordisk Seeks More Time to Address US Sen. Bernie Sanders' Questions on Drug Pricing	08/05	MT
NOVO NORDISK : Barclays remains its Buy rating	07/05	ZD
NOVO NORDISK : UBS sticks Neutral	06/05	ZD
Novo Nordisk: share price falls, analyst adjusts target	03/05	CF
NOVO NORDISK : DZ Bank sticks Neutral	03/05	ZD
NOVO NORDISK : Stifel lowers target slightly	03/05	CF
NOVO NORDISK : Buy rating from Deutsche Bank	03/05	ZD
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data	03/05	RE
NOVO NORDISK : JP Morgan gives a Buy rating	03/05	ZD
NOVO NORDISK : Q1 beat; guidance upgrade but sentiment nonetheless dampened by price reductions	02/05
NOVO NORDISK : Gets a Buy rating from Barclays	02/05	ZD
NOVO NORDISK : UBS gives a Neutral rating	02/05	ZD